Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3979607 | Bulletin du Cancer | 2010 | 6 Pages |
Abstract
Despite the extraordinary development of the medical treatment of kidney cancer, its treatment remains very surgical in localized and metastatic stage. Advances in surgery have accompanied the advent of targeted therapies. The laparoscopy has become the reference procedure for radical nephrectomy in the case of T1-T2 tumors. Partial nephrectomy, currently widespread, should be the first surgical procedure to consider in cases of tumors less than 4Â cm. Partial nephrectomy for tumors between 4 and 7Â cm is feasible for selected patients with favorable tumor localization. In the future, the use of neo-adjuvant anti-angiogenesis agents could broaden the scope of partial nephrectomy. Laparoscopic partial nephrectomy is spreading but is still considered as a therapeutic option, conducted in reference centres. In case of metastatic disease, pending the results of randomized trials including patients on anti-angiogenesis agents, cytoreductive nephrectomy remains indicated for patients in good general condition with kidney cancer metastatic immediately.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G. Ploussard, A. de La Taille,